Massmutual Trust CO Fsb Mirum Pharmaceuticals, Inc. Transaction History
Massmutual Trust CO Fsb
- $3.4 Billion
- Q1 2025
A detailed history of Massmutual Trust CO Fsb transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 79 shares of MIRM stock, worth $3,822. This represents 0.0% of its overall portfolio holdings.
Number of Shares
79
Previous 79
-0.0%
Holding current value
$3,822
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MIRM
# of Institutions
225Shares Held
55.4MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$329 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$231 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$157 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$135 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$123 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.78B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...